Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Change in Inventory (2022 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Change in Inventory for 4 consecutive years, with $4.9 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 1.67% to $4.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Dec 2025, down 26.12% year-over-year, with the annual reading at $7.5 million for FY2025, 26.12% down from the prior year.
  • Change in Inventory for Q4 2025 was $4.9 million at Rhythm Pharmaceuticals, up from $2.5 million in the prior quarter.
  • The five-year high for Change in Inventory was $4.9 million in Q4 2025, with the low at -$479000.0 in Q2 2025.
  • Average Change in Inventory over 4 years is $1.8 million, with a median of $1.4 million recorded in 2022.
  • The sharpest move saw Change in Inventory skyrocketed 31800.0% in 2023, then plummeted 113.74% in 2025.
  • Over 4 years, Change in Inventory stood at $1.2 million in 2022, then decreased by 29.98% to $862000.0 in 2023, then skyrocketed by 462.18% to $4.8 million in 2024, then increased by 1.67% to $4.9 million in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $4.9 million, $2.5 million, and -$479000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.